Photo courtesy of Yonhap News

 

 

[Alpha Biz= Paul Lee] Bukwang Pharmaceutical announced on the 27th that it will acquire 60 million shares of Korea Union Pharmaceutical for KRW 30 billion, securing a 75% ownership stake.

The acquisition, equivalent to 8.8% of Bukwang’s equity, will be carried out through a third-party allotment capital increase paid in cash. The company said the deal will help secure manufacturing capabilities and support production expansion and business growth.

Bukwang’s total assets stood at approximately KRW 476.3 billion as of its latest financial statements, with the acquisition amount accounting for 6.3% of total assets. The board approved the transaction on April 27, 2026.

Korea Union Pharmaceutical is a drug manufacturing company with a capital of approximately KRW 3.96 billion.

 

 

 

 

AlphaBIZ Paul Lee(hoondork1977@alphabiz.co.kr)